22项鼻窦结果测试(SNOT-22)的预测效用:范围综述
本文为范围综述,系统检索PubMed、Scopus、Cochrane Library和Web of Science,纳入39项评估SNOT-22预测效用的研究。结论认为SNOT-22是有潜力的预测工具,但需进一步验证后方可应用于临床。
要点
- SNOT-22已被研究用于预测诊断、干预结局和患者治疗偏好三类场景。
- 现有预测模型尚需外部验证,临床应用需谨慎。
核心结论
- SNOT-22是一种多用途工具,有潜力预测多种诊断、结局和患者偏好,但其预测应用需进一步验证后才能用于临床实践。
研究设计与样本
- 范围综述,系统检索PubMed、Scopus、Cochrane Library和Web of Science,最终纳入39项评估SNOT-22预测效用的研究。
临床怎么用
- 临床可将SNOT-22作为预测诊断、干预结局或患者偏好的辅助工具,但应意识到现有预测模型尚未充分验证,不宜直接替代临床判断。
局限性
- 作者指出,基于SNOT-22应答的预测需进一步研究验证,才能安全应用于临床实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The 22-item sino-nasal outcome test (SNOT-22) is a widely used and powerful patient-reported outcomes measure for chronic rhinosinusitis (CRS). More recently; however, the SNOT-22 has been evaluated as a predictive tool for multiple conditions. The objective of this scoping review is to investigate the extent to which SNOT-22 is used in this manner and present this information in a way useful for clinicians. METHODS: A systematic search of PubMed, Scopus, Cochrane Library, and Web of Science was performed. Studies that evaluated SNOT-22s predictive utility were considered for eligibility in this scoping review. RESULTS: A total of 39 studies met eligibility. The SNOT-22 was found to be used as a predictive tool in three broad categories: (1) to predict a diagnosis, (2) to predict an outcome of an intervention, and (3) to predict a patient treatment preference. Thirteen studies were included in the diagnosis category, which made up ten different individual predictions. Twenty-four studies were included in the outcomes category and investigated 17 different individual predictions. Finally, two studies were included in the patient preferences category, which together made one prediction. CONCLUSIONS: The SNOT-22 is a versatile tool that has the potential to be used in predicting various diagnoses, outcomes, and patient preferences. However, care must be taken in applying these predictions to clinical practice, as further research must be done in validating these predictions based on SNOT-22 responses.
引用
- Liu M, Liu J, Weitzel EK, et al. The predictive utility of the 22-item sino-nasal outcome test (SNOT-22): A scoping review. Int Forum Allergy Rhinol. 2021. PMID: 34585521. doi:10.1002/alr.22888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。